【摘要】 乳腺癌是女性最常见的恶性肿瘤。得益于综合治疗手段的进步,患者的5年生存率已接近90%,保障幸存者的生活质量应该成为治疗方案中的核心内容。乳腺癌患者面临罹患淋巴水肿的终身风险。尽管采用侵袭性更小的治疗方法,发病率仍然较高,大约1/5的幸存者最终出现乳腺癌相关淋巴水肿(breast cancer-related lymphedema, BCRL),这对她们的生活质量造成不利影响。本篇综述总结了近年来的研究进展,主要探讨BCRL的发病机制、诊断技术、危险因素及治疗方法,为临床防治提供参考,努力最终改善乳腺癌幸存者的生活质量。更多还原

【Abstract】 Breast cancer is the most common malignant tumor in women. Thanks to the advancement of comprehensive treatment methods, the 5-year survival rate is close to 90%. Guaranteeing the quality of life of survivors should be the core component of a treatment plan. Breast cancer patients face a lifetime risk of lymphedema. Incidence rate is still high despite the use of less aggressive treatment, with about one in five of the survivors eventually developing breast cancer-related lymphedema(BCRL), which has a negative effect on their quality of life. This review summarizes the research progress in recent years, mainly explores the pathogenesis, diagnostic techniques, risk factors and treatment methods of BCRL, to provide experience for clinical prevention and treatment, and we endeavor to ultimately improve the quality of life of breast cancer survivors.更多还原